antibody-drug binding technology

Korean chipmakers South Korea asks US for tailored approach to chip tariffs

South Korea has officially requested that the US take a distinct approach in its ongoing probe into foreign semiconductor technology and related dow...

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Korean chipmakers SK Hynix makes strides in CXL technology, escalating rivalry

SK Hynix Inc., the leading global high-bandwidth memory (HBM) chip provider, has moved faster than its rivals in the commercialization of the next-g...

Bio & Pharma Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Bio & Pharma Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Shipping & Shipbuilding Samsung Heavy makes breakthrough in FLNG liquefaction technology

Samsung Heavy Industries Co., a major Korean shipbuilder, has made a breakthrough in its liquefaction technology for floating liquefied natural gas ...

Bio & Pharma Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Bio & Pharma SillaJen: First to use lab-grown human tissue to find best cancer drug dose

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Hydrogen economy Samsung E&A buys Norwegian Nel stake for hydrogen business push

South Korea’s Samsung E&A Co. has purchased a stake in Norway’s hydrogen technology company Nel ASA at 47.6 billion won ($32.8 milli...

Bio & Pharma Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Shipping & Shipbuilding HD Hyundai, Palantir chiefs discuss AI shipyard, defense technology

Chung Kisun, executive vice chairman of the world’s largest shipbuilder HD Hyundai Co., has met with Alex Karp, CEO of Palantir Technologies I...

Bio & Pharma Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Machinery Hyundai Rotem inks $1.5 bn Morocco train supply deal

South Korea’s Hyundai Rotem Co. said on Wednesday it has won a 2.2 trillion won ($1.5 billion) train order from Morocco, the biggest single de...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Aerospace & Defense S.Korea’s defense order backlog reaches record $73.1 billion at end-2024

South Korea’s seven major defense companies saw their combined order backlog reach a record 105.6 trillion won ($73.1 billion) at the end of 2...

Private equity EQT targets healthcare, technology, business service providers in Korea

EQT, the largest private equity firm in Europe, is setting its sights on healthcare, technology companies and business service providers in South Ko...

Bio & Pharma Lotte Biologics eyes first ADC CDMO order in 2025

SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Bio & Pharma SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US

South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...

Automobiles Hyundai Mobis to boost US production to cope with Trump

LAS VEGAS -- Hyundai Mobis Co., the world’s fifth-largest auto parts maker, plans to beef up its US production to cope with President-elect Do...

Korean Innovators at CES 2025 LG Electronics bets big on humanoid robots: CEO Cho

LAS VEGAS – South Korea’s top home appliance maker LG Electronics Inc. has thrown down the gauntlet to frontrunners in the AI robot race...

Automobiles Hyundai Motor vows record investment of $16.7 bn in South Korea

Hyundai Motor Group will invest 24.3 trillion won ($16.7 billion) this year in South Korea, the largest-ever annual investment in its home country, ...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Automobiles Hyundai AutoEver establishes JV in Indonesia

South Korea's Hyundai AutoEver Corp. said on Monday it built the joint venture PT Terra Link technology in Indonesia with India's MapmyIndia. T...

Artificial intelligence SK Telecom invests $3 mn in AI-powered video analysis startup Twelve Labs

South Korea’s top mobile carrier SK Telecom Co. said on Friday it will invest $3 million in Twelve Labs Inc., a Korean AI-powered video analys...

Bio & Pharma Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

Steel POSCO Future M develops technology to make electrode rods

POSCO Future M Co., a battery material and steel manufacturing equipment supplier, said on Thursday it has developed electrode rod manufacturing tec...

Electronics Korean displays regain top spot with premium information tech OLEDs

South Korean display makers regained ground in the global organic light-emitting diode (OLED) panel market in the second quarter, elbowing out the p...

Bio & Pharma SK Biopharm submits NDA of epilepsy drug to China

South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...

Cloud computing CJ OliveNetworks to expand cloud management biz

South Korea's CJ OliveNetworks said on Wednesday it will expand its managed service provider (MSP) in the cloud industry, utilizing Naver Cloud and ...